CLINICAL THERAPEUTICS AND HEMATOLOGIC COMPLICATIONS: Edited by W. Joseph McCunePractical management strategies for benign hypermobility syndromesMinhas, DeebaAuthor Information Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA Correspondence to Deeba Minhas, Clinical Lecturer, Department of Internal Medicine, Division of Rheumatology, University of Michigan, 300 North Ingalls Building Ann Arbor, Michigan 48109-5422, USA. Tel: +734 936 5566; fax: +734 763 1253; e-mail: [email protected] Current Opinion in Rheumatology: May 2021 - Volume 33 - Issue 3 - p 249-254 doi: 10.1097/BOR.0000000000000798 Buy Metrics Abstract Purpose of review Patients with symptomatic hypermobility syndrome such as hypermobile Ehlers-Danlos syndromes (hEDS) and hypermobility spectrum disorders (HSD) commonly present to rheumatologists with joint pain and functional disability. Providers often have difficulty with diagnosis due to a lack of knowledge on the range of associated manifestations and the available therapeutic modalities. This review will discuss recent updates on diagnostic measures and treatment options for rheumatologists to help patients navigate hEDS/HSD. Recent findings This article describes newer diagnostic measures and assessment of hEDS/HSD manifestations. Evidence supporting physical therapy and occupational therapy is provided, as well as recent updates on assistive devices, compressive garments, orthoses, and surgical interventions. Given patient heterogeneity specific guidance about the amount and type of therapies required to produce a beneficial effect is lacking. Treatment should be individualized, and many of the studies focus on regional joint complaints rather than a whole-body approach. Summary Physical therapy and occupational therapy remain the cornerstone of treatment. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.